Skip to main content
Top
Published in: Medical Oncology 1/2015

01-01-2015 | Original Paper

Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions

Authors: Maoxi Liu, Kunli Du, Zhongxue Fu, Shouru Zhang, Xingye Wu

Published in: Medical Oncology | Issue 1/2015

Login to get access

Abstract

Hypoxia is a common characteristic of solid tumors. Recent studies confirmed that phospholipase D2 (PLD2) plays significant roles in cancer progression. In this study, correlation between the expression of PLD2 and the change in the protein level of hypoxia-inducible factor 1-alpha (HIF1-α) was studied. Thirty human colon cancer tissues were examined for the expression of HIF1-α and PLD2 protein, and mRNA levels. SW480 and SW620 cells were exposed to normoxia (20 %) or hypoxia (<1 %). HIF1-α and PLD2 protein, and mRNA levels were analyzed by Western blot and qRT-PCR, respectively. Growth studies were conducted on cells with HIF1-α inhibition through xenograft tumor model. Finally, PLD2 protein was detected by Western blot analysis in vivo. There was a positive correlation between HIF1-α and PLD2 in colon cancer tissues. Hypoxic stress induced PLD2 mRNA and protein expression in SW480 and SW620 cells. Cells transfected with HIF1-α siRNA showed attenuation of hypoxia stress-induced PLD2 expression. In vivo growth decreased in response to HIF1-α and PLD2 inhibition. These results suggest that PLD2 expression in colon cancer cells is up-regulated via HIF1-α in response to hypoxic stress and underscores the crucial role of HIF1-α-induced PLD2 in tumor growth.
Literature
1.
2.
3.
go back to reference Tsunaki H, Yasunori K. Mammalian phospholipase D: structure regulation and physiological function of phospholipase D and its link to pathology. Adv Biochem Health Dis. 2014;10:343–58. Tsunaki H, Yasunori K. Mammalian phospholipase D: structure regulation and physiological function of phospholipase D and its link to pathology. Adv Biochem Health Dis. 2014;10:343–58.
4.
go back to reference Young-Hoon L, Young-Seuk B. Phospholipase D2 downregulation reduces cellular senescence through a reactive oxygen species P53-P21 pathway. FEBS Lett. 2014;588(17):3251–8.CrossRef Young-Hoon L, Young-Seuk B. Phospholipase D2 downregulation reduces cellular senescence through a reactive oxygen species P53-P21 pathway. FEBS Lett. 2014;588(17):3251–8.CrossRef
5.
go back to reference Gomez-Cambronero J. Phospholipase D in cell signaling :from a myriad of cell functions to cancer growth and metastasis. J Biol Chem. 2014;289(33):22557–66.PubMedCrossRef Gomez-Cambronero J. Phospholipase D in cell signaling :from a myriad of cell functions to cancer growth and metastasis. J Biol Chem. 2014;289(33):22557–66.PubMedCrossRef
6.
go back to reference Nakashima S, Nozawa Y. Possible role of phospholipase D in cellular differentiation and apoptosis. Chem Phys Lipids. 1999;98:153–64.PubMedCrossRef Nakashima S, Nozawa Y. Possible role of phospholipase D in cellular differentiation and apoptosis. Chem Phys Lipids. 1999;98:153–64.PubMedCrossRef
7.
go back to reference Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J, Morris AJ, Frohman MA. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem. 1995;720:29640–3. Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J, Morris AJ, Frohman MA. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem. 1995;720:29640–3.
8.
go back to reference Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Froham MA. phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997;7:191–201.PubMedCrossRef Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Froham MA. phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997;7:191–201.PubMedCrossRef
9.
go back to reference Peng JHF, Feng Y, Rhodes PG. Down-regulation of phospholipase D2 mRNA in neonatal rat brainstem and cerebellum after Hypoxia-Ischemia. Neurochem Res. 2006;31:1191–6.PubMedCrossRef Peng JHF, Feng Y, Rhodes PG. Down-regulation of phospholipase D2 mRNA in neonatal rat brainstem and cerebellum after Hypoxia-Ischemia. Neurochem Res. 2006;31:1191–6.PubMedCrossRef
10.
go back to reference Mozzicato S, Joshi BV, Jacobson KA, Liang BT. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. FASEB J. 2004;18(2):406–8.PubMed Mozzicato S, Joshi BV, Jacobson KA, Liang BT. Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia. FASEB J. 2004;18(2):406–8.PubMed
11.
go back to reference Yamakawa H, Banno Y, Nakashima S, Sawada M, Yamada J, Yoshimura S, et al. Increased phospholipase D2 activity during hypoxia-induced death of PC12 cells: its possible anti-apoptotic role. Neuro Rep. 2000;16:3647–50. Yamakawa H, Banno Y, Nakashima S, Sawada M, Yamada J, Yoshimura S, et al. Increased phospholipase D2 activity during hypoxia-induced death of PC12 cells: its possible anti-apoptotic role. Neuro Rep. 2000;16:3647–50.
12.
go back to reference Uchida N, Okamura S, Kuwano H. Phospholipase D activity in human gastric carcinoma. Anticancer Res. 1999;19:77–86. Uchida N, Okamura S, Kuwano H. Phospholipase D activity in human gastric carcinoma. Anticancer Res. 1999;19:77–86.
13.
go back to reference Ahn MJ, Park SY, Kim WK, Cho JH, Chang BJ, Kim DJ, et al. A single nucleotide polymorphism in the phospholipase D1 gene is associated with risk of non-small lung cancer. Int J Biomed Sci. 2012;8(2):121–8.PubMedCentralPubMed Ahn MJ, Park SY, Kim WK, Cho JH, Chang BJ, Kim DJ, et al. A single nucleotide polymorphism in the phospholipase D1 gene is associated with risk of non-small lung cancer. Int J Biomed Sci. 2012;8(2):121–8.PubMedCentralPubMed
14.
go back to reference Park MH, Min DS. Quercetin-induced downregulation of PLD1 inhibits proliferation and invasion in U87 glioma cells. Biochem Biophys Res Commun. 2011;412(4):710–5.PubMedCrossRef Park MH, Min DS. Quercetin-induced downregulation of PLD1 inhibits proliferation and invasion in U87 glioma cells. Biochem Biophys Res Commun. 2011;412(4):710–5.PubMedCrossRef
15.
go back to reference Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA. HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. Oncogene. 2008;27(19):2746–53.PubMedCrossRef Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA. HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. Oncogene. 2008;27(19):2746–53.PubMedCrossRef
16.
go back to reference Noh DY, Ahn SJ, Lee RA, Park IA, Kim JH, Suh PG, Ryu SH, Lee KH, Ham LS. Overexpression of phospholipase D in human breast cancer tissues. Cancer Lett. 2000;161:207–14.PubMedCrossRef Noh DY, Ahn SJ, Lee RA, Park IA, Kim JH, Suh PG, Ryu SH, Lee KH, Ham LS. Overexpression of phospholipase D in human breast cancer tissues. Cancer Lett. 2000;161:207–14.PubMedCrossRef
17.
go back to reference Henkels KM, Boivin GP, Dudley ES, Berberich SJ, Gomez-Cambronero J. Phospholipase D drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model. Oncogene. 2013;32:5551–62.PubMedCentralPubMedCrossRef Henkels KM, Boivin GP, Dudley ES, Berberich SJ, Gomez-Cambronero J. Phospholipase D drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model. Oncogene. 2013;32:5551–62.PubMedCentralPubMedCrossRef
18.
19.
go back to reference Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF1-α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 1998;394:485–90.PubMedCrossRef Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF1-α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 1998;394:485–90.PubMedCrossRef
20.
go back to reference Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–4.PubMedCentralPubMedCrossRef Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–4.PubMedCentralPubMedCrossRef
21.
go back to reference Tanimoto K, Makino Y, Pereira T, et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBOJ. 2000;19:4298–309.CrossRef Tanimoto K, Makino Y, Pereira T, et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBOJ. 2000;19:4298–309.CrossRef
22.
go back to reference Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Bio. 2000;2:423–7.CrossRef Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Bio. 2000;2:423–7.CrossRef
23.
go back to reference Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J. 2008;275:2991–3002.PubMedCrossRef Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J. 2008;275:2991–3002.PubMedCrossRef
24.
25.
go back to reference Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006;59:15–26.PubMedCrossRef Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006;59:15–26.PubMedCrossRef
26.
go back to reference Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105:659–69.PubMedCrossRef Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105:659–69.PubMedCrossRef
27.
go back to reference Sansom L, Hutchins GGA, Shires M, Hemmings G, et al. Hypoxia response proteins HIF1-alpha, CAIX and GLUT1 as potential prognostic biomarkers in colorectal cancer. J Pathol. 2012;228(suppl.1):S7. Sansom L, Hutchins GGA, Shires M, Hemmings G, et al. Hypoxia response proteins HIF1-alpha, CAIX and GLUT1 as potential prognostic biomarkers in colorectal cancer. J Pathol. 2012;228(suppl.1):S7.
28.
go back to reference Yoshimura H, Dhar DK, Kohno H, Kubota H, et al. Prognostic impact of hypoxia-inducible factors 1 alpha and 2 alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res. 2004;10(24):8554–60.PubMedCrossRef Yoshimura H, Dhar DK, Kohno H, Kubota H, et al. Prognostic impact of hypoxia-inducible factors 1 alpha and 2 alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res. 2004;10(24):8554–60.PubMedCrossRef
29.
go back to reference Kang DW, Park M-K, Oh H-J, et al. Phospholipase D1 Has a pivotal role in interleukin-1 beta-driven chronic autoimmune arthritis through regulation of NF-kappa B, hypoxia-inducible factor 1 alpha, and FoxO3a. Mol Cell Biol. 2013;33(14):2760–72.PubMedCentralPubMedCrossRef Kang DW, Park M-K, Oh H-J, et al. Phospholipase D1 Has a pivotal role in interleukin-1 beta-driven chronic autoimmune arthritis through regulation of NF-kappa B, hypoxia-inducible factor 1 alpha, and FoxO3a. Mol Cell Biol. 2013;33(14):2760–72.PubMedCentralPubMedCrossRef
30.
go back to reference Wu XY, Fu ZX, Wang XH, Shen W. Identification of differential proteins in colon cancer SW480 cells with HIF1-alpha silence by proteome analysis. Neoplasma. 2010;57(4):299–305.PubMedCrossRef Wu XY, Fu ZX, Wang XH, Shen W. Identification of differential proteins in colon cancer SW480 cells with HIF1-alpha silence by proteome analysis. Neoplasma. 2010;57(4):299–305.PubMedCrossRef
31.
go back to reference Oshimoto H, Okamura S, Yoshida M, Mori M. Increased activity and expression of Phospholipase D2 in human colorectal cancer. Oncol Res. 2003;14:31–7.PubMed Oshimoto H, Okamura S, Yoshida M, Mori M. Increased activity and expression of Phospholipase D2 in human colorectal cancer. Oncol Res. 2003;14:31–7.PubMed
32.
go back to reference Saito M, Iwadate M, Higashimoto M, Ono K, et al. Expression of phospholipase D2 in human colorectal carcinoma. Oncol Rep. 2007;18:1329–34.PubMed Saito M, Iwadate M, Higashimoto M, Ono K, et al. Expression of phospholipase D2 in human colorectal carcinoma. Oncol Rep. 2007;18:1329–34.PubMed
33.
go back to reference Yamada Y, Hamajima N, Kato T, Iwata H, et al. Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J Mol Med. 2003;81:126–31.PubMed Yamada Y, Hamajima N, Kato T, Iwata H, et al. Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer. J Mol Med. 2003;81:126–31.PubMed
34.
go back to reference Kong D, Su G, Zha L, Zhang H, Xiang J, et al. Coexpression of HMGA2 and Oct4 predicts an unfavorable progression in human gastric cancer. Med Oncol. 2014;31(130):3–10. Kong D, Su G, Zha L, Zhang H, Xiang J, et al. Coexpression of HMGA2 and Oct4 predicts an unfavorable progression in human gastric cancer. Med Oncol. 2014;31(130):3–10.
35.
go back to reference Nishida A, Emoto K, Shimizu M, Uozumi T, Yamawaki S. Brain ischemia decreases phosphatidylcholine-phospholipase D but not phosphatidylinositol-phospholipase C in rats. Stroke. 1994;25:1247–51.PubMedCrossRef Nishida A, Emoto K, Shimizu M, Uozumi T, Yamawaki S. Brain ischemia decreases phosphatidylcholine-phospholipase D but not phosphatidylinositol-phospholipase C in rats. Stroke. 1994;25:1247–51.PubMedCrossRef
36.
go back to reference Kang DW, Min DS. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NF-kappa B signaling pathway and enhances invasion of breast cancer cells. Cancer Lett. 2010;294:125–33.PubMedCrossRef Kang DW, Min DS. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NF-kappa B signaling pathway and enhances invasion of breast cancer cells. Cancer Lett. 2010;294:125–33.PubMedCrossRef
37.
go back to reference Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, et al. P50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006;66:11432–40.PubMedCrossRef Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, et al. P50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006;66:11432–40.PubMedCrossRef
38.
go back to reference Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/Hej and C58BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.PubMedCrossRef Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/Hej and C58BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.PubMedCrossRef
39.
go back to reference Park MH, Ahn BH, Hong YK, et al. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kB/Sp1-mediated signaling pathways [J]. Carcinogenesis. 2009;30(2):356–65.PubMedCrossRef Park MH, Ahn BH, Hong YK, et al. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kB/Sp1-mediated signaling pathways [J]. Carcinogenesis. 2009;30(2):356–65.PubMedCrossRef
40.
go back to reference Kang DW, Min DS. positive feedback regulation between phospholipase D and wnt signaling promotes wnt-driven anchorage-independent growth of colorectal cancer cells. Plos One. 2010;5(8):2109. Kang DW, Min DS. positive feedback regulation between phospholipase D and wnt signaling promotes wnt-driven anchorage-independent growth of colorectal cancer cells. Plos One. 2010;5(8):2109.
41.
go back to reference Shen Q, Stanton ML, Feng W, Rodriquez ME, Ramondetta L, Chen L, et al. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTOR pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010;4(1):13–21.PubMedCentralPubMed Shen Q, Stanton ML, Feng W, Rodriquez ME, Ramondetta L, Chen L, et al. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTOR pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010;4(1):13–21.PubMedCentralPubMed
Metadata
Title
Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions
Authors
Maoxi Liu
Kunli Du
Zhongxue Fu
Shouru Zhang
Xingye Wu
Publication date
01-01-2015
Publisher
Springer US
Published in
Medical Oncology / Issue 1/2015
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0394-9

Other articles of this Issue 1/2015

Medical Oncology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.